Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Incyte Corp (INCY)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 15,692,139
  • Shares Outstanding, K 211,970
  • Annual Sales, $ 1,536 M
  • Annual Income, $ -313,140 K
  • 36-Month Beta 0.75
  • Price/Sales 10.21
  • Price/Cash Flow 85.06
  • Price/Book 9.63

Price Performance

See More
Period Period Low Period High Performance
1-Month
66.35 +11.57%
on 05/29/18
75.15 -1.49%
on 06/21/18
+5.60 (+8.18%)
since 05/25/18
3-Month
60.22 +22.92%
on 05/03/18
88.66 -16.50%
on 03/27/18
-9.03 (-10.87%)
since 03/23/18
52-Week
60.22 +22.92%
on 05/03/18
140.11 -47.16%
on 08/31/17
-62.25 (-45.68%)
since 06/23/17

Most Recent Stories

More News
Incyte (INCY) Announces Positive Results on Jakafi for GVHD

Incyte (INCY) reports positive results on Jakafi from the REACH trial for the indication of acute GVHD. The company plans to file a sNDA for the drug in the third quarter.

MRK : 61.38 (-0.15%)
LLY : 85.92 (-0.17%)
INCY : 74.03 (unch)
NVS : 74.38 (-0.91%)
After Yesterday's Rally of 1.38% Shares Could Potentially Pullback

Incyte Corp (NASDAQ:INCY) traded in a range yesterday that spanned from a low of $73.72 to a high of $75.15. Yesterday, the shares gained 1.4%, which took the trading range above the 3-day high of $74.30...

INCY : 74.03 (unch)
Look for Shares of Incyte Corp to Potentially Pullback after Yesterday's 1.38% Rise

Incyte Corp (NASDAQ:INCY) traded in a range yesterday that spanned from a low of $73.72 to a high of $75.15. Yesterday, the shares gained 1.4%, which took the trading range above the 3-day high of $74.30...

INCY : 74.03 (unch)
Incyte to Present Diversified Development Portfolio and Opportunities for Accelerated Growth at 2018 Investor and Analyst Event

--Pivotal REACH1 study of Jakafi(R) (ruxolitinib) in steroid-refractory acute GVHD met primary endpoint; sNDA submission expected in the third quarter of 2018

INCY : 74.03 (unch)
Incyte Announces REACH1 Pivotal Trial Meets Primary Endpoint of Overall Response Rate for Ruxolitinib (Jakafi(R)) in Steroid-Refractory Acute Graft-Versus-Host Disease

Incyte Corporation (Nasdaq:INCY) today announced positive topline results from its ongoing pivotal Phase 2 REACH1 trial evaluating ruxolitinib (Jakafi(R)) in combination with corticosteroids...

INCY : 74.03 (unch)
Loncar Cancer Immunotherapy Index Conducts Semi-Annual Rebalance

Loncar Investments, LLC today announced the result of the semi-annual rebalance and reconstitution of the Loncar Cancer Immunotherapy Index, a stock index of top companies developing...

CLDX : 0.52 (-6.64%)
JNCE : 8.51 (+4.42%)
IDRA : 1.44 (-2.04%)
RCUS : 15.45 (-3.56%)
BLCM : 7.95 (unch)
INO : 4.24 (+1.19%)
FATE : 12.84 (-1.83%)
MRTX : 51.35 (-2.00%)
SRNE : 6.35 (-3.05%)
MOR : 30.60 (+1.26%)
AGEN : 2.50 (+2.88%)
INCY : 74.03 (unch)
ZYME : 16.05 (-0.37%)
NK : 2.93 (+3.53%)
PIRS : 5.19 (-0.38%)
NLNK : 5.10 (-1.16%)
Incyte Corp Set to Possibly Pullback After Yesterday's Rally of 4.84%

Incyte Corp (NASDAQ:INCY) traded in a range yesterday that spanned from a low of $70.77 to a high of $74.16. Yesterday, the shares gained 4.8%, which took the trading range above the 3-day high of $71.95...

INCY : 74.03 (unch)
SmarTrend Watching for Potential Pullback in Shares of Incyte Corp After 4.84% Gain

Incyte Corp (NASDAQ:INCY) traded in a range yesterday that spanned from a low of $70.77 to a high of $74.16. Yesterday, the shares gained 4.8%, which took the trading range above the 3-day high of $71.95...

INCY : 74.03 (unch)
Lilly to Unveil New Data at the Annual European Congress of Rheumatology, Furthering Commitment to Scientific Discovery in Immunology

Eli Lilly and Company (NYSE: LLY) announced today it will present new data from its immunology portfolio, including cornerstone treatments OLUMIANT® (baricitinib) and Taltz® (ixekizumab), at the Annual...

LLY : 85.92 (-0.17%)
INCY : 74.03 (unch)
Watch for Incyte Corp to Potentially Pullback After Gaining 1.41% Yesterday

Incyte Corp (NASDAQ:INCY) traded in a range yesterday that spanned from a low of $68.83 to a high of $71.41. Yesterday, the shares gained 1.4%, which took the trading range above the 3-day high of $70.20...

INCY : 74.03 (unch)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 48% Buy with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Minimum. Long term indicators are in flux.

See More Share

Trade INCY with:

Business Summary

Incyte Corporation is a Wilmington, Delaware-based biopharmaceutical company focused on the discovery, development, and commercialization of proprietary therapeutics. Their first commercial product, Jakafi (ruxolitinib), is approved in the United States for patients with intermediate or high-risk myelofibrosis...

See More

Key Turning Points

2nd Resistance Point 75.66
1st Resistance Point 74.84
Last Price 74.03
1st Support Level 72.77
2nd Support Level 71.52

See More

52-Week High 140.11
Fibonacci 61.8% 109.59
Fibonacci 50% 100.17
Fibonacci 38.2% 90.74
Last Price 74.03
52-Week Low 60.22

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.

Free Barchart Webinar